JAKARTA - PT Deltomed Laboratories as a company that accepts the merger (merger) and PT Marguna Tarulata Astagina Pill Kita Farma as a self-incorporating company, has merged to strengthen business lines in the traditional herbal medicine sector.
This merger is official and effective as of December 1, 2024. This merger is a strategy that is carried out to establish itself as a player in the herbal medicine industry in Indonesia.
Chief Executive Officer of PT Deltomed Laboratories Muljo Rahardjo said this merger was an important step taken by Deltomed and Marguna in an effort to strengthen our business line, especially for linu reckless products and energy recovery products.
"Of course, with this strategic step, the distribution network and marketing strategy for products owned by Marguna, especially for Pilkita, will be stronger. Based on internal data that we have the Pilkita market share in Indonesia compared to other linu legislative products, it reaches 12 percent," he said, in a written statement, Thursday, December 19.
The chemical, pharmaceutical and traditional medicine industry has proven to be one of the signature foreign exchange contributor sectors. In 2023, the Ministry of Industry said the export value for pharmaceutical industrial products, chemical products and traditional medicines increased by 8.78 percent compared to 2022 in the fourth quarter, with an export value of 543.7 million US dollars.
After the merger, Pilkita products (pegal linu herbal medicine), Tenaga X ( herbal medicine stamina and energy), Sari Temulawak ( herbal medicine of appetite and children's health), Herbalmon (high blood herbal medicine), Herbalforce ( herbal medicine supplement), EurycoMax (male stamina herbal medicine), and CinnaMax ( diabetes herbal medicine) will be produced and distributed under the auspices of Deltomed.
Deltomed has indeed been known as a player in the herbal medicine industry in Indonesia. Throughout the founding of the company, Deltomed has released a variety of trusted products such as Antangin totaling, Antangin
SEE ALSO:
"We see that the herbal medicine market will continue to increase. Therefore, we feel that the development of the natural medicinal industry in Indonesia needs to continue to be improved in order to be able to compete in the global market. Moreover, this opportunity is supported by the use of natural medicinal drugs which are widely found in Indonesia. In addition, herbal medicine has also become a culture in Indonesia which has officially been included in the 13th Indonesian Intangible Cultural Heritage which is included in the UNESCO list," said Muljo.
Deltomed will continue to be committed to making herbal medicines able to compete in the global arena by combining Indonesia's natural potential and the latest technology it has to create various herbal-based products to help the healing process naturally.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)